These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 36343352)
21. A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder. Faden J; Citrome L Schizophr Res; 2024 Jun; 268():265-281. PubMed ID: 38290941 [TBL] [Abstract][Full Text] [Related]
22. The risk of suicide after clozapine discontinuation: Cause for concern. Patchan KM; Richardson C; Vyas G; Kelly DL Ann Clin Psychiatry; 2015 Nov; 27(4):253-6. PubMed ID: 26554366 [TBL] [Abstract][Full Text] [Related]
23. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593 [TBL] [Abstract][Full Text] [Related]
24. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
25. Suicide attempts in schizophrenia: the role of command auditory hallucinations for suicide. Harkavy-Friedman JM; Kimhy D; Nelson EA; Venarde DF; Malaspina D; Mann JJ J Clin Psychiatry; 2003 Aug; 64(8):871-4. PubMed ID: 12927000 [TBL] [Abstract][Full Text] [Related]
26. Suicidal risk during treatment with clozapine: a meta-analysis. Hennen J; Baldessarini RJ Schizophr Res; 2005 Mar; 73(2-3):139-45. PubMed ID: 15653256 [TBL] [Abstract][Full Text] [Related]
27. Clozapine in severe mood disorders. Zarate CA; Tohen M; Baldessarini RJ J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540 [TBL] [Abstract][Full Text] [Related]
28. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215 [TBL] [Abstract][Full Text] [Related]
29. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
30. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. Nemani KL; Greene MC; Ulloa M; Vincenzi B; Copeland PM; Al-Khadari S; Henderson DC Clin Schizophr Relat Psychoses; 2019; 12(4):168-176. PubMed ID: 29164928 [TBL] [Abstract][Full Text] [Related]
31. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Lerner V; Libov I; Kotler M; Strous RD Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862 [TBL] [Abstract][Full Text] [Related]
33. Clozapine in the treatment of neuroleptic-induced blepharospasm: a report of 4 cases. Levin H; Reddy R J Clin Psychiatry; 2000 Feb; 61(2):140-3. PubMed ID: 10732662 [TBL] [Abstract][Full Text] [Related]
34. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835 [TBL] [Abstract][Full Text] [Related]
35. Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia. Friedman L; Jesberger JA; Meltzer HY Psychiatry Res; 1992 Jan; 41(1):25-36. PubMed ID: 1348583 [TBL] [Abstract][Full Text] [Related]
36. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Radomsky ED; Haas GL; Mann JJ; Sweeney JA Am J Psychiatry; 1999 Oct; 156(10):1590-5. PubMed ID: 10518171 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of the metabolic syndrome among patients receiving clozapine. Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB Am J Psychiatry; 2006 Jul; 163(7):1273-6. PubMed ID: 16816234 [TBL] [Abstract][Full Text] [Related]
38. Sleep, suicide behaviors, and the protective role of sleep medicine. Bishop TM; Walsh PG; Ashrafioun L; Lavigne JE; Pigeon WR Sleep Med; 2020 Feb; 66():264-270. PubMed ID: 31727433 [TBL] [Abstract][Full Text] [Related]
39. Transcultural differences in suicide attempters: analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder. Altamura AC; Mundo E; Bassetti R; Green A; Lindenmayer JP; Alphs L; Meltzer HY Schizophr Res; 2007 Jan; 89(1-3):140-6. PubMed ID: 17097854 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]